Search results for " Myocardial Infarction"

showing 10 items of 247 documents

Magnetic Resonance Assessment of Left Ventricular Ejection Fraction at Any Time Post-Infarction for Prediction of Subsequent Events in a Large Multic…

2021

Background Magnetic resonance imaging (MRI) is the most accurate imaging technique for left ventricular ejection fraction (LVEF) quantification, but as yet the prognostic value of LVEF assessment at any time after ST-segment elevation myocardial infarction (STEMI) for subsequent major adverse cardiac event (MACE) prediction is uncertain. Purpose To explore the prognostic impact of MRI-derived LVEF at any time post-STEMI to predict subsequent MACE (cardiovascular death or re-admission for acute heart failure). Study Type Prospective. Population One thousand thirteen STEMI patients were included in a multicenter registry. Field Strength/Sequence 1.5-T. Balanced steady-state free precession (c…

medicine.medical_specialtyMagnetic Resonance SpectroscopyPopulationContrast MediaMagnetic Resonance Imaging CineGadoliniumVentricular Function Left030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionPredictive Value of TestsInternal medicineMedicineHumansRadiology Nuclear Medicine and imagingMyocardial infarctionProspective StudiesRegistriescardiovascular diseasesStage (cooking)educationriskeducation.field_of_studyEjection fractionmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Magnetic resonance imagingStroke Volumeleft ventricular ejection fractionmedicine.diseasePrognosisMagnetic Resonance ImaginghumanitiesST-segment elevation myocardial infarctionHeart failureCardiologycardiovascular systemST Elevation Myocardial InfarctionprognosisbusinessMacecirculatory and respiratory physiology
researchProduct

Gender-related disparities in the treatment and outcomes in patients with non-ST-segment elevation myocardial infarction: results from the Polish Reg…

2017

Introduction: Gender-related differences in the treatment of patients with non-ST elevation myocardial infarction (NSTEMI) have been reported in many previous studies despite the fact that an equal approach is recommended in all current guidelines. The aim of the study was to investigate whether gender-related discrepancies in the management of NSTEMI patients have changed. Material and methods: Between 2012 and 2014 a total of 66,667 patients (38.3% of whom were women) with the final diagnosis of NSTEMI were included into the retrospective analysis of the Polish Registry of Acute Coronary Syndromes (PL-ACS). Differences in clinical profile, treatment, and outcomes were analysed. Results: W…

medicine.medical_specialtyMultivariate analysismedicine.medical_treatmentAge adjustmentPopulationelderly03 medical and health sciences0302 clinical medicineClinical ResearchInternal medicinemedicineST segment030212 general & internal medicineMyocardial infarctioneducationeducation.field_of_studybusiness.industryMortality rateinvasive treatmentPercutaneous coronary interventionGeneral Medicinemedicine.diseaseGender relatedmortalitynon-ST elevation myocardial infarctionwomenbusinessArchives of Medical Science
researchProduct

Beyond Reperfusion Networks in ST-segment Elevation Myocardial Infarction: Assessment of Quality of Care

2017

medicine.medical_specialtyMyocardial InfarctionMyocardial Reperfusion030204 cardiovascular system & hematologyElectrocardiography03 medical and health sciences0302 clinical medicineSt elevation myocardial infarctionInternal medicinemedicineHumansST segment030212 general & internal medicineMyocardial infarctionQuality of careQuality of Health CareMyocardial reperfusionmedicine.diagnostic_testbusiness.industryElevationGeneral Medicinemedicine.diseaseCardiologyST Elevation Myocardial InfarctionbusinessElectrocardiographyRevista Española de Cardiología (English Edition)
researchProduct

Tissue characterization comparison of culprit lesions between stable coronary disease and ST elevation myocardial infarction patients

2013

medicine.medical_specialtyNecrosisbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionTissue characterizationCoronary diseasemedicine.diseaseCulpritAtheromaSt elevation myocardial infarctionInternal medicineFactor V LeidenmedicineCardiologyRadiologymedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Cardiovascular risk and events in polycystic ovary syndrome

2009

Young women with polycystic ovary syndrome (PCOS) present a high risk for cardiovascular disease because of the presence of abdominal obesity, insulin resistance and androgen excess. In addition, they present with endothelial dysfunction and early signs of atherosclerosis (increased carotid intima-media thickness and increased coronary calcium). However, the evidence of increased cardiovascular events during the postmenopausal age is relatively small, although some recent studies have indicated a slight increase in the severity of cardiovascular disease in women who had PCOS during their fertile age. The discrepancy between cardiovascular risk in young age and postmenopausal cardiovascular …

medicine.medical_specialtyPCOS Cardiovascular risk myocardial infarction stroke atherosclerosisSettore MED/09 - Medicina InternaDiseaseAndrogen ExcessSeverity of Illness IndexSettore MED/13 - EndocrinologiaInsulin resistanceRisk FactorsInternal medicinePrevalencemedicineHumansEndothelial dysfunctionAbdominal obesityEvidence-Based Medicinebusiness.industryHyperandrogenismObstetrics and GynecologyGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSettore MED/40 - Ginecologia E OstetriciaPolycystic ovaryPostmenopauseEndocrinologyPremenopauseCardiovascular DiseasesFemalemedicine.symptombusinessDyslipidemiaPolycystic Ovary SyndromeClimacteric
researchProduct

Cardiac computed tomography assessment of the near term impact of percutaneous ventricular restoration therapy (parachute®) on mitral valve geometry

2015

Objectives The aim of current study is to assess the near term impact of percutaneous ventricular restoration therapy (PVR), Parachute® on mitral valve (MV) geometry by cardiac computed tomography (CCT). Background Recent data demonstrates the feasibility of PVR for treatment of post anterior myocardial infarction (MI) heart failure. Little is known, however, about the interaction of the device and left ventricular structures, particularly the MV apparatus. Methods This is a retrospective Core Laboratory analysis of Parachute Trials’ CCT data. Patients with paired (before and after Parachute implant) CCT acquisitions were included into analysis. MV geometric parameters were measured. Result…

medicine.medical_specialtyPercutaneousCardiac computed tomographybusiness.industryDiastoleAnterior myocardial infarctionGeometryGeneral Medicine030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureHeart failureMitral valveInternal medicinemedicineCardiologyRadiology Nuclear Medicine and imaging030212 general & internal medicineImplantCore laboratoryCardiology and Cardiovascular MedicinebusinessCatheterization and Cardiovascular Interventions
researchProduct

Evaluating the quality of implantation of percutaneous ventricular restoration device (Parachute®) by cardiac computed tomography

2016

Background The Parachute is a novel percutaneously implanted ventricular partitioning device (VPD) that has emerged as a safe and feasible treatment option for patients with heart failure following anterior wall myocardial infarction. VPD efficacy is likely dependent on optimal device placement, but to date there are no published data examining the effect of device positioning on patient outcomes. Methods and results We retrospectively identified 32 patients successfully implanted with the Parachute device, all of whom underwent cardiac computed tomography (CCT) at baseline and after 6 months of follow-up. Patients were divided into two groups based on self-reported improvement in New York …

medicine.medical_specialtyPercutaneousbusiness.industrymedicine.medical_treatmentRetrospective cohort studyGeneral MedicineStroke volume030204 cardiovascular system & hematologymedicine.diseaseSurgery03 medical and health sciences0302 clinical medicineHeart failuremedicineRadiology Nuclear Medicine and imagingAnterior Wall Myocardial Infarction030212 general & internal medicineImplantCardiology and Cardiovascular MedicinebusinessVentricular remodelingCardiac catheterizationCatheterization and Cardiovascular Interventions
researchProduct

Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-…

2019

Abstract Aims ST-segment elevation myocardial infarction (STEMI) guidelines recommend primary percutaneous coronary intervention (pPCI) as the default reperfusion strategy when feasible ≤120 min of diagnostic ECG, and a pharmaco-invasive strategy otherwise. There is, however, a lack of direct evidence to support the guidelines, and in real-world situations, pPCI is often performed beyond recommended timelines. To assess 5-year outcomes according to timing of pPCI (timely vs. late) compared with a pharmaco-invasive strategy (fibrinolysis with referral to PCI centre). Methods and results The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) programme c…

medicine.medical_specialtyPercutaneousmedicine.medical_treatment[SDV]Life Sciences [q-bio]Myocardial InfarctionAcute myocardial infarction030204 cardiovascular system & hematology03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicineReperfusion therapyFibrinolytic Agents[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemFibrinolysismedicineHumansST segment030212 general & internal medicineMyocardial infarctioncardiovascular diseasesTimingPrimary PCIbusiness.industryFibrinolysisHazard ratioPercutaneous coronary interventionmedicine.diseaseLong-term outcome3. Good health[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system[SDV] Life Sciences [q-bio]Treatment OutcomeEmergency medicineConventional PCIST Elevation Myocardial InfarctionCardiology and Cardiovascular Medicinebusiness
researchProduct

Periodontitis, coronary heart disease and myocardial infarction: treat one, benefit all

2020

: Periodontal disease is conventionally defined as an inflammatory condition affecting the tissues surrounding and supporting the teeth (i.e. gum and periodontium). Recent statistics show that the prevalence of this condition is continuously growing worldwide, thus raising severe healthcare concerns, not only for local problems emerging from poor oral health, but also for the potential risk of developing systemic complications. Therefore, this article aims to provide an update on the intriguing association between periodontitis, coronary heart disease (CHD) and/or myocardial infarction (MI). Taken together, the available published information seems to support the existence of a significant …

medicine.medical_specialtyPeriodontitis coronary heart disease myocardial infarctionCoronary Artery Disease030204 cardiovascular system & hematologyOverweightCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologymedicineAnimalsHumansMyocardial infarctionEndothelial dysfunctioncoronary heart diseasePeriodontitisPeriodontitisbusiness.industryHematologyGeneral MedicinePeriodontiummedicine.diseaseCoronary heart diseaseTreatment Outcomemyocardial infarctionmedicine.symptomHydroxymethylglutaryl-CoA Reductase Inhibitorsbusiness030215 immunology
researchProduct

Causal linear parametric model for baroreflex gain assessment in patients with recent myocardial infarction

2001

Spectral and cross-spectral analysis of R-R interval and systolic arterial pressure (SAP) spontaneous fluctuations have been proposed for noninvasive evaluation of baroreflex sensitivity (BRS). However, results are not in good agreement with clinical measurements. In this study, a bivariate parametric autoregressive model with exogenous input (ARXAR model), able to divide the R-R variability into SAP-related and -unrelated parts, was used to quantify the gain (αARXAR) of the baroreflex regulatory mechanism. For performance assessing, two traditional noninvasive methods based on frequency domain analysis [spectral, baroreflex gain by autogressive model (αAR); cross-spectral, baroreflex gain…

medicine.medical_specialtyPhysiologySystoleEntropyRR intervalMyocardial InfarctionHemodynamicsBlood PressureBaroreflexAutoregressive modelSpectral analysiElectrocardiographyPhenylephrineHeart RateInternal medicinePhysiology (medical)MedicineHumansVasoconstrictor AgentsIn patientAnalysis of VarianceModels Statisticalbusiness.industryModels CardiovascularBaroreflexMiddle AgedR-R-SAP transfer functionSurgeryBlood pressureBaroreflex sensitivityParametric modelCardiologySystolic arterial pressureRegression AnalysisCardiology and Cardiovascular MedicinebusinessRecent myocardial infarction
researchProduct